Impact of 68Ga-PSMA PET on the management of patients with prostate cancer: a systematic review and meta-analysis

S Han, S Woo, YJ Kim, CH Suh - European urology, 2018 - Elsevier
Context 68 Gallium prostate-specific membrane antigen positron emission tomography (68
Ga-PSMA PET) is an emerging imaging modality for assessment of prostate cancer. Recent …

Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review

FE von Eyben, G Roviello, T Kiljunen… - European journal of …, 2018 - Springer
Aims There is a controversy as to the relative efficacy of 177 Lu prostate specific membrane
antigen (PSMA) radioligand therapy (RLT) and third-line treatment for patients with …

Efficacy, predictive factors, and prediction nomograms for 68Ga-labeled prostate-specific membrane antigen–ligand positron-emission tomography/computed …

I Rauscher, C Düwel, B Haller, C Rischpler, MM Heck… - European urology, 2018 - Elsevier
Abstract Recently, 68 Ga-labeled prostate-specific membrane antigen (PSMA)–ligand
positron-emission tomography (PET) imaging has been shown to improve detection rates in …

Current status of theranostics in prostate cancer

I Virgolini, C Decristoforo, A Haug, S Fanti… - European journal of …, 2018 - Springer
The aim of this review is to report on the current status of prostate-specific membrane
antigen (PSMA)-directed theranostics in prostate cancer (PC) patients. The value of 68 Ga …

Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the …

FE Lecouvet, DE Oprea-Lager, Y Liu, P Ost… - The Lancet …, 2018 - thelancet.com
Oligometastatic disease represents a clinical and anatomical manifestation between
localised and polymetastatic disease. In prostate cancer, as with other cancers, recognition …

68Ga-PSMA positron emission tomography/computerized tomography for primary diagnosis of prostate cancer in men with contraindications to or negative …

E Lopci, A Saita, M Lazzeri, G Lughezzani… - The Journal of …, 2018 - Elsevier
Purpose 68 Ga labeled prostate specific membrane antigen positron emission tomography/
computerized tomography may represent the most promising imaging modality to identify …

One-stop-shop whole-body 68Ga-PSMA-11 PET/MRI compared with clinical nomograms for preoperative T and N staging of high-risk prostate cancer

M Thalgott, C Düwel, I Rauscher… - Journal of Nuclear …, 2018 - Soc Nuclear Med
Our aim was to assess the diagnostic potential of 1-stop-shop prostate-specific membrane
antigen ligand (68Ga-PSMA-11) PET/MRI compared with preoperative staging nomograms …

PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives

S Zschaeck, F Lohaus, M Beck, G Habl, S Kroeze… - Radiation …, 2018 - Springer
Abstract 68 Gallium prostate specific membrane antigen (PSMA) ligand positron emission
tomography (PET) is an increasingly used imaging modality in prostate cancer, especially in …

Radiotherapy for recurrent prostate cancer: 2018 recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group

H Lieng, AJ Hayden, DRH Christie, BJ Davis… - Radiotherapy and …, 2018 - Elsevier
The management of patients with biochemical, local, nodal, or oligometastatic relapsed
prostate cancer has become more challenging and controversial. Novel imaging modalities …

Advances in urologic imaging: prostate-specific membrane antigen ligand PET imaging

MS Hofman, A Iravani, T Nzenza… - Urologic …, 2018 - urologic.theclinics.com
Prostate cancer (PCa) is one of the most common malignancies in men worldwide and leads
to substantial morbidity and mortality. Imaging is indicated in multiple aspects of PCa …